Acorah Software Products - Accounts Production 15.0.600 false true 30 June 2023 1 July 2022 false 1 July 2023 30 June 2024 30 June 2024 10235042 Mr Timothy Francis Mrs Amanda-Louise Francis Mr Paul Carey iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 10235042 2023-06-30 10235042 2024-06-30 10235042 2023-07-01 2024-06-30 10235042 frs-core:CurrentFinancialInstruments 2024-06-30 10235042 frs-core:ComputerEquipment 2024-06-30 10235042 frs-core:ComputerEquipment 2023-07-01 2024-06-30 10235042 frs-core:ComputerEquipment 2023-06-30 10235042 frs-core:FurnitureFittings 2024-06-30 10235042 frs-core:FurnitureFittings 2023-07-01 2024-06-30 10235042 frs-core:FurnitureFittings 2023-06-30 10235042 frs-core:PlantMachinery 2024-06-30 10235042 frs-core:PlantMachinery 2023-07-01 2024-06-30 10235042 frs-core:PlantMachinery 2023-06-30 10235042 frs-core:ShareCapital 2024-06-30 10235042 frs-core:RetainedEarningsAccumulatedLosses 2024-06-30 10235042 frs-bus:PrivateLimitedCompanyLtd 2023-07-01 2024-06-30 10235042 frs-bus:FilletedAccounts 2023-07-01 2024-06-30 10235042 frs-bus:SmallEntities 2023-07-01 2024-06-30 10235042 frs-bus:AuditExempt-NoAccountantsReport 2023-07-01 2024-06-30 10235042 frs-bus:SmallCompaniesRegimeForAccounts 2023-07-01 2024-06-30 10235042 frs-bus:Director1 2023-07-01 2024-06-30 10235042 frs-bus:Director2 2023-07-01 2024-06-30 10235042 frs-bus:Director3 2023-07-01 2024-06-30 10235042 frs-countries:EnglandWales 2023-07-01 2024-06-30 10235042 2022-06-30 10235042 2023-06-30 10235042 2022-07-01 2023-06-30 10235042 frs-core:CurrentFinancialInstruments 2023-06-30 10235042 frs-core:ShareCapital 2023-06-30 10235042 frs-core:RetainedEarningsAccumulatedLosses 2023-06-30
Registered number: 10235042
Exemplar Medical Limited
Unaudited Financial Statements
For The Year Ended 30 June 2024
Contents
Page
Balance Sheet 1—2
Notes to the Financial Statements 3—5
Page 1
Balance Sheet
Registered number: 10235042
2024 2023
Notes £ £ £ £
FIXED ASSETS
Tangible Assets 4 1,206 1,465
1,206 1,465
CURRENT ASSETS
Stocks 20,456 20,228
Debtors 5 521 475
Cash at bank and in hand 60 -
21,037 20,703
Creditors: Amounts Falling Due Within One Year 6 (94,694 ) (85,217 )
NET CURRENT ASSETS (LIABILITIES) (73,657 ) (64,514 )
TOTAL ASSETS LESS CURRENT LIABILITIES (72,451 ) (63,049 )
PROVISIONS FOR LIABILITIES
Deferred Taxation (278 ) (278 )
NET LIABILITIES (72,729 ) (63,327 )
CAPITAL AND RESERVES
Called up share capital 7 1,000 1,000
Profit and Loss Account (73,729 ) (64,327 )
SHAREHOLDERS' FUNDS (72,729) (63,327)
Page 1
Page 2
For the year ending 30 June 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime.
The company has taken advantage of section 444(1) of the Companies Act 2006 and opted not to deliver to the registrar a copy of the company's Profit and Loss Account.
On behalf of the board
Mr Paul Carey
Director
02/10/2024
The notes on pages 3 to 5 form part of these financial statements.
Page 2
Page 3
Notes to the Financial Statements
1. General Information
Exemplar Medical Limited is a private company, limited by shares, incorporated in England & Wales, registered number 10235042 . The registered office is 6 Cresswell Park, Blackheath, London, SE3 9RJ.
2. Accounting Policies
2.1. Basis of Preparation of Financial Statements
The financial statements have been prepared under the historical cost convention and in accordance with Financial Reporting Standard 102 section 1A Small Entities "The Financial Reporting Standard applicable in the UK and Republic of Ireland" and the Companies Act 2006.
2.2. Tangible Fixed Assets and Depreciation
Tangible fixed assets are measured at cost less accumulated depreciation and any accumulated impairment losses. Depreciation is provided at rates calculated to write off the cost of the fixed assets, less their estimated residual value, over their expected useful lives on the following bases:
Plant & Machinery 15% on reducing balance
Fixtures & Fittings 15% on reducing balance
Computer Equipment 15% on reducing balance
2.3. Stocks and Work in Progress
Stocks and work in progress are valued at the lower of cost and net realisable value after making due allowance for obsolete and slow-moving stocks. Cost includes all direct costs and an appropriate proportion of fixed and variable overheads. Work-in-progress is reflected in the accounts on a contract by contract basis by recording turnover and related costs as contract activity progresses.
2.4. Taxation
Income tax expense represents the sum of the tax currently payable and deferred tax.
The tax currently payable is based on taxable profit for the year. Taxable profit differs from profit as reported in the statement of comprehensive income because of items of income or expense that are taxable or deductible in other years and items that are never taxable or deductible. The company's liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the end of the reporting period.
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance
sheet date.
Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from
those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that
have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the
timing difference.
Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they
will be recovered against the reversal of deferred tax liabilities or other future taxable profits.
Current or deferred tax for the year is recognised in profit or loss, except when they related to items that are recognised in other comprehensive income or directly in equity, in which case, the current and deferred tax is also recognised in other comprehensive income or directly in equity respectively.
3. Average Number of Employees
Average number of employees, including directors, during the year was: NIL (2023: NIL)
- -
Page 3
Page 4
4. Tangible Assets
Plant & Machinery Fixtures & Fittings Computer Equipment Total
£ £ £ £
Cost
As at 1 July 2023 670 1,099 2,115 3,884
As at 30 June 2024 670 1,099 2,115 3,884
Depreciation
As at 1 July 2023 416 685 1,318 2,419
Provided during the period 45 73 141 259
As at 30 June 2024 461 758 1,459 2,678
Net Book Value
As at 30 June 2024 209 341 656 1,206
As at 1 July 2023 254 414 797 1,465
5. Debtors
2024 2023
£ £
Due within one year
Trade debtors 475 475
VAT 46 -
521 475
6. Creditors: Amounts Falling Due Within One Year
2024 2023
£ £
Trade creditors 401 400
Bank loans and overdrafts - 4
Other creditors 19,706 19,706
Directors' loan accounts 74,587 65,107
94,694 85,217
7. Share Capital
2024 2023
£ £
Allotted, Called up and fully paid 1,000 1,000
Page 4
Page 5
8. Related Party Transactions
Included in other creditors is an amount of £65,107 (£56,817 in 2022), owed to the company directors Mr P Carey, Mr T Francis and Mrs A Francis. This loan is interest free and no repayment terms have been agreed.
Page 5